Mapping the Duchenne Muscular Dystrophy (DMD) Patient Journey
With the launch of a ground-breaking gene therapy on the horizon, our client sought a deep understanding of the Duchenne Muscular Dystrophy (DMD) patient journey to ensure a seamless and impactful introduction.
AI-powered Digital Ethnography
Leveraging our AI-driven digital ethnography, we analyzed online interactions from DMD-affected families and those with experience in gene therapy for Spinal Muscular Atrophy (SMA). These candid conversations provided rich, emotional insights into patient challenges and aspirations.
A Compass for Compassionate Marketing
By analyzing over 65,000 online conversations, we mapped two detailed patient journeys. The first highlighted the multifaceted challenges faced by DMD patients and their families—from financial strains and social isolation to emotional and logistical hurdles. The second provided insights into the experiences of those affected by gene therapies, offering valuable benchmarks from social media.
With these insights, our client was able to:
- Develop impactful marketing strategies
- Pinpoint key moments to enhance patient and family experiences
- Craft initiatives that resonate with distinct patient profiles
- Ensure future marketing remains patient- and family-centric
